Patents by Inventor William Jason Fox

William Jason Fox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347446
    Abstract: The present technology is generally directed to interatrial shunting systems and associated devices and methods. For example, a system configured in accordance with embodiments of the present technology can include a shunting element implantable into a patient at or adjacent a septal wall. The shunting element can have a lumen that fluidly connects a left atrium and a right atrium of the patient to facilitate blood flow therebetween when the shunting element is implanted. In some embodiments, the system further includes a flow control element to selectively control blood flow between the left atrium and the right atrium.
    Type: Application
    Filed: June 18, 2020
    Publication date: November 3, 2022
    Inventors: Brian Fahey, Tom Saul, Claudio Argento, Reza Kassayan, William Jason Fox, Stefan Schreck, Anthony Pantages, Amr Salahieh, Marwan Berrada, Susan Philip, Veronica Neiman
  • Publication number: 20220313484
    Abstract: In an example, a cryotherapy device includes an elongated shaft, and a cryotherapy delivery member coupled to a distal end of the elongated shaft. The cryotherapy delivery member is configured to apply, from a fixed position in a nasal cavity, thermal energy to at least one of a plurality of nerves in the nasal cavity or a plurality of branches of a nerve in the nasal cavity.
    Type: Application
    Filed: September 17, 2020
    Publication date: October 6, 2022
    Inventors: Brian Fahey, William Jason Fox
  • Publication number: 20220257298
    Abstract: Devices and methods for treating conditions such as rhinitis are disclosed herein where a distal end of a probe shaft is introduced through the nasal cavity where the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity. The distal end may be positioned into proximity of a nasal tissue region having at least one nasal nerve. Once suitably positioned, the distal end may be reconfigured from the first configuration to a second configuration which is shaped to contact and follow the nasal tissue region and the at least one nasal nerve may then be ablated via the distal end. Ablation may be performed using various mechanisms, such as cryotherapy, and optionally under direct visualization.
    Type: Application
    Filed: July 8, 2020
    Publication date: August 18, 2022
    Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
  • Publication number: 20220233832
    Abstract: In an example, a method for delivering an anesthetic agent to a target tissue in a nasal cavity of a patient includes inserting a cryotherapy device into the nasal cavity of the patient. The cryotherapy device includes a cryotherapy delivery feature and one or more protrusions. The method also includes positioning the cryotherapy delivery feature in contact with the target tissue, and delivering, using the cryotherapy delivery feature, a cryotherapy treatment to the target tissue. After inserting the cryotherapy device into the nasal cavity, the method includes actuating the one or more protrusions from a retracted state to an extended state. After actuating the one or more protrusions to the extended state, the method includes penetrating the target tissue with the one or more protrusions. After penetrating the target tissue, the method includes delivering, via the one or more protrusions, an anesthetic agent into the target tissue.
    Type: Application
    Filed: June 12, 2020
    Publication date: July 28, 2022
    Inventors: Brian Fahey, William Jason Fox, Vahid Saadat
  • Publication number: 20220226623
    Abstract: The present technology is directed to adjustable interatrial shunting systems that selectively control blood flow between the left atrium and the right atrium of a patient. The adjustable interatrial devices include a shunting element having an outer surface configured to engage native tissue and an inner surface defining a lumen that enables blood to flow from the left atrium to the right atrium when the system is deployed across the septal wall. The systems can include an actuation assembly for selectively adjusting a geometry of the lumen and/or a geometry of a lumen orifice to control the flow of blood through the lumen.
    Type: Application
    Filed: October 20, 2021
    Publication date: July 21, 2022
    Inventors: Brian Fahey, Scott Robertson, William L. Gould, William Jason Fox, Claudio Argento, Anthony Pantages, Miles Alexander, Peter Andriola
  • Publication number: 20220226000
    Abstract: The present technology includes systems and methods for invasively adjusting implantable devices for selectively controlling fluid flow between a first body region and a second body region of a patient. For example, in many of the embodiments described herein, a catheter can be used to mechanically and/or electrically engage an implanted medical device. Once the catheter engages the medical device, the catheter can (i) increase a dimension associated with the medical device, such as through mechanical expansion forces, and/or (ii) decrease a dimension associated with the medical device, such as by heating a shape memory component of the medical device above a phase transition temperature.
    Type: Application
    Filed: April 5, 2022
    Publication date: July 21, 2022
    Inventors: Miles Alexander, Peter Andriola, Brian Fahey, William Jason Fox, Anthony Pantages, Scott Robertson, Jace Valls
  • Publication number: 20220218964
    Abstract: The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes interatrial shunting systems that include a shunting element having a lumen extending therethrough that is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in a patient. The system can also include an energy receiving component for receiving energy from an energy source positioned external to the body, an energy storage component for storing the received energy, and/or a flow control mechanism for adjusting a geometry of the lumen.
    Type: Application
    Filed: January 11, 2022
    Publication date: July 14, 2022
    Inventors: Brian Fahey, Peter Andriola, William Jason Fox
  • Patent number: 11376028
    Abstract: According to some embodiments, the present technology includes a device for the disruption and/or removal of obstructive material in a blood vessel. The device can comprise an elongated shaft having a proximal portion, a distal portion, and a lumen extending therebetween. The device can further comprise a capture structure carried by the distal portion of the elongated shaft and having a greater cross-sectional dimension than a cross-sectional dimension of the elongated shaft. The capture structure can comprise an opening at a first end portion that is fluidly coupled to the lumen of the elongated shaft, a fluid impermeable sidewall enclosing an interior region, and an opening extending through a thickness of the sidewall. A portion of the sidewall surrounding the opening can be configured to deform towards or away from the interior region such that a cross-sectional dimension of the opening increases to receive the obstructive material therethrough.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: July 5, 2022
    Assignee: Inquis Medical, Inc.
    Inventors: Vahid Saadat, William Jason Fox, Richard Christian Ewers, Mojgan Saadat, Sherwin Llamido
  • Publication number: 20220142652
    Abstract: The present technology includes systems and methods for invasively adjusting implantable devices for selectively controlling fluid flow between a first body region and a second body region of a patient. For example, in many of the embodiments described herein, a catheter can be used to mechanically and/or electrically engage an implanted medical device. Once the catheter engages the medical device, the catheter can (i) increase a dimension associated with the medical device, such as through mechanical expansion forces, and/or (ii) decrease a dimension associated with the medical device, such as by heating a shape memory component of the medical device above a phase transition temperature.
    Type: Application
    Filed: November 11, 2021
    Publication date: May 12, 2022
    Inventors: Miles Alexander, Peter Andriola, Brian Fahey, William Jason Fox, Anthony Pantages, Scott Robertson, Jace Valls
  • Publication number: 20220133395
    Abstract: Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: William Jason Fox, David Moosavi, Mojgan Saadat, Vahid Saadat, Caroline Sobek, Neekon Saadat
  • Patent number: 11278356
    Abstract: Apparatus and methods for treating and monitoring conditions such as rhinitis are disclosed herein. The technology utilizes ultrasound scans to identify target treatment sites, and monitor the treatment of a patient undergoing a treatment. The treatment may be an ablation treatment of a nasal nerve, for example the PNN for the treatment of nasal conditions, such as rhinitis. The ultrasound scans are performed within the nasal cavity with an ultrasound probe or a combined ultrasound and ablation probe and may use Doppler, A-mode, B-mode, M-mode or other ultrasound and non-ultrasound modalities to detect and monitor the target treatment sites.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: March 22, 2022
    Assignee: Arrinex, Inc.
    Inventors: Brian Fahey, William Jason Fox, Bryant Lin, Mojgan Saadat, Vahid Saadat
  • Patent number: 11253312
    Abstract: Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: February 22, 2022
    Assignee: Arrinex, Inc.
    Inventors: William Jason Fox, David Moosavi, Mojgan Saadat, Vahid Saadat, Caroline Sobek, Neekon Saadat
  • Patent number: 11253685
    Abstract: The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes interatrial shunting systems that include a shunting element having a lumen extending therethrough that is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in a patient. The system can also include an energy receiving component for receiving energy from an energy source positioned external to the body, an energy storage component for storing the received energy, and/or a flow control mechanism for adjusting a geometry of the lumen.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: February 22, 2022
    Assignee: Shifamed Holdings, LLC
    Inventors: Brian Fahey, Peter Andriola, William Jason Fox
  • Publication number: 20210369320
    Abstract: Systems, devices, and methods involve ablation of tissue to treat rhinitis and/or other nasal conditions. Implementations allow treatment of tissue in the confined space of the nasal cavity. Additionally, implementations allow targeted treatment tissue to be ablated, while protecting other non-treatment tissue from unintentional collateral effects that might be produced by the ablation. According to an example implementation, an approach for treating a nasal condition includes advancing a probe into a nasal cavity, the probe including a shaft and a cryotherapy element coupled to the shaft. The approach also includes cryogenically cooling a target treatment site with the cryotherapy element to treat at least one nasal nerve. Additionally, the approach includes transmitting a focused ultrasound beam to a target heating site to increase a temperature tissue at the target heating site.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 2, 2021
    Inventors: Brian Fahey, William Jason Fox, Mojgan Saadat, Vahid Saadat
  • Publication number: 20210370032
    Abstract: The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes interatrial shunting systems that include a shunting element having a lumen extending therethrough that is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in a patient. The system can also include an energy receiving component for receiving energy from an energy source positioned external to the body, an energy storage component for storing the received energy, and/or a flow control mechanism for adjusting a geometry of the lumen.
    Type: Application
    Filed: December 4, 2020
    Publication date: December 2, 2021
    Inventors: Brian Fahey, Peter Andriola, William Jason Fox
  • Patent number: 11160961
    Abstract: The present technology is directed to adjustable interatrial shunting systems that selectively control blood flow between the left atrium and the right atrium of a patient. The adjustable interatrial devices include a shunting element having an outer surface configured to engage native tissue and an inner surface defining a lumen that enables blood to flow from the left atrium to the right atrium when the system is deployed across the septal wall. The systems can include an actuation assembly for selectively adjusting a geometry of the lumen and/or a geometry of a lumen orifice to control the flow of blood through the lumen.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: November 2, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Brian Fahey, Scott Robertson, William L. Gould, William Jason Fox, Claudio Argento, Anthony Pantages, Miles Alexander, Peter Andriola
  • Publication number: 20210330418
    Abstract: An isolation barrier and method of using it. The isolation barrier includes a mask with a face opening and at least one access opening in front of the subject's nose and/or mouth and an enclosure having a first enclosure opening attached around the access opening, a second enclosure opening, and flexible material extending from the first enclosure opening to the second enclosure opening and defining an enclosure interior, the flexible material comprising at least one area through which the enclosure interior can be viewed, the mask and enclosure interior defining a medical procedure field extending from the subject's nose and mouth to the second enclosure opening when the isolation barrier is in place on the subject's face.
    Type: Application
    Filed: March 2, 2021
    Publication date: October 28, 2021
    Inventors: Mojgan SAADAT, Vahid SAADAT, William Jason FOX, William L. GOULD, Matthew Allison HERRON, Andrew Ivan POUTIATINE
  • Patent number: D933816
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: October 19, 2021
    Assignee: Arrinex, Inc.
    Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
  • Patent number: D940856
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: January 11, 2022
    Assignee: Arrinex, Inc.
    Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
  • Patent number: D969318
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: November 8, 2022
    Assignee: Arrinex, Inc.
    Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron